GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Cash Flow for Dividends

Universal Ibogaine (TSXV:IBO) Cash Flow for Dividends : C$0.00 Mil (TTM As of Jan. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Cash Flow for Dividends?

Universal Ibogaine's cash flow for dividends for the three months ended in Jan. 2025 was C$0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jan. 2025 was C$0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Universal Ibogaine Cash Flow for Dividends Historical Data

The historical data trend for Universal Ibogaine's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Cash Flow for Dividends Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Cash Flow for Dividends
Get a 7-Day Free Trial - - - - -

Universal Ibogaine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Universal Ibogaine Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Cash Flow for Dividends
Comparable Companies
TSXV:CYTO TSXV:IOT TSXV:RKV XCNQ:GLOW XCNQ:LOBE XCNQ:ASEP TSXV:MRVL TSXV:QPT TSX:APLI XCNQ:RIZE VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
IBOGF:USA JC4:Germany
Address
C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Website
https://www.universalibogaine.com
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.
Executives
Ian Rabb Senior Officer

Universal Ibogaine Headlines

From GuruFocus

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

By Marketwired • 09-16-2024